| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/26/2007 | US20070173462 Treatment of diseases associated with the use of antibiotics |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173439 Administering formulation comprising polypeptide and muteins, fused proteins, muteins, functional derivatives and active fragments for treating autoimmune diseases, Type I diabetes, rheumatoid arthritis, graft rejections, inflammatory bowel disease, sepsis, multiple sclerosis, ischemic heart disease etc. |
| 07/26/2007 | US20070172930 process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereof |
| 07/26/2007 | US20070172928 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/26/2007 | US20070172927 Immune complexes comprising proteins of human immunodeficiency virus type 2 (HIV-2), antibodies against proteins of HIV-2, methods and kits employing proteins of HIV-2, and immunogenic compositions comprising proteins of HIV-2 |
| 07/26/2007 | US20070172923 Homogeneous preparations of il-28 and il-29 |
| 07/26/2007 | US20070172920 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 07/26/2007 | US20070172901 Method for the evaluation of the functional status of the growth factor receptor protein expressed in malignant tumors |
| 07/26/2007 | US20070172900 Diagnostic marker for cancer |
| 07/26/2007 | US20070172892 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 07/26/2007 | US20070172877 Methods for preventing cattle reproductive diseases |
| 07/26/2007 | US20070172520 Immunotargeting of Nonionic Surfactant Vesicles |
| 07/26/2007 | US20070172517 Compositions capable of facilitation penetration across a biological barrier |
| 07/26/2007 | US20070172516 Increasing of the resorption of substances via skin and mucous membranes |
| 07/26/2007 | US20070172504 In vivo cell surface engineering |
| 07/26/2007 | US20070172503 Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines |
| 07/26/2007 | US20070172502 Compositions and methods for treatment of Toxoplasma gondii and other apicomplexans |
| 07/26/2007 | US20070172501 Method of immunizing humans against salmonella typhi using a Vi-rEPA conjugate vaccine |
| 07/26/2007 | US20070172500 Anthrax antitoxins |
| 07/26/2007 | US20070172499 Immunotherapy for humans |
| 07/26/2007 | US20070172498 Polypeptides for inducing a protective immune response against staphyloococcus aureus |
| 07/26/2007 | US20070172497 BoNT/A PEPTIDES AND METHODS OF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY |
| 07/26/2007 | US20070172496 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 07/26/2007 | US20070172495 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 07/26/2007 | US20070172494 Cold-adapted equine influenza viruses |
| 07/26/2007 | US20070172493 12832, a novel human kinase-like molecule and uses thereof |
| 07/26/2007 | US20070172491 Vaccine composition comprising an immunoadjuvant compound consisting of a rho gtpase family activator |
| 07/26/2007 | US20070172490 Leukocyte stimulation matrix |
| 07/26/2007 | US20070172489 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 07/26/2007 | US20070172488 cell proliferation-inhibiting activity by ADCC (antibody-dependent cell-mediated cytotoxicity) activity and CDC (complement-dependent cytotoxicity); hepatic cancer |
| 07/26/2007 | US20070172487 Alpha-enolase specific antibody and method of use |
| 07/26/2007 | US20070172486 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis |
| 07/26/2007 | US20070172485 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics |
| 07/26/2007 | US20070172484 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 07/26/2007 | US20070172483 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 07/26/2007 | US20070172482 using a hapten comprising tetracarboxy phenyl porphyrin zinc or cobalt complexes, to generate monoclonal or polyclonal antibodies and testing for inhibitory effects of the antibodies on the gelatinase B; metalloenzyme inhibitors |
| 07/26/2007 | US20070172481 GDF3 propeptides and related methods |
| 07/26/2007 | US20070172480 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172479 Adding calcium chloride or magnesium chloride to mixture in order to reduce viscosity of anti-myostatin antibody formulation in fluid |
| 07/26/2007 | US20070172478 Methods of treating skin disorders |
| 07/26/2007 | US20070172477 Use of soluble cd14 for treatment of diseases |
| 07/26/2007 | US20070172476 Method of treating B-cell neoplasms or Hodgkin's lymphoma |
| 07/26/2007 | US20070172475 Highly concentrated, liquid formulations of anti-egfr antibodies |
| 07/26/2007 | US20070172474 Dairy components effective for fat loss |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172461 Polyepitope vaccines |
| 07/26/2007 | US20070172457 Interleukins-21 and 22 |
| 07/26/2007 | US20070172454 Use of il-6/il-6 chimera in huntington's disease |
| 07/26/2007 | US20070172448 Method for detecting the specificity of activated lymphocyte |
| 07/26/2007 | US20070172427 Biofunctionalized quantum dots for biological imaging |
| 07/26/2007 | US20070172423 Composition and method for modulating vasculogenesis for angiogenesis |
| 07/26/2007 | DE102006051941A1 Multifunctional active agent mixture, useful as auxiliary material in virus vaccine or vaccine to treat cancer, comprises fraction of specific peptide in polypetide chain and fraction with essential and non-essential amino acids |
| 07/26/2007 | CA2637903A1 Viable non-toxic gram negative bacteria |
| 07/26/2007 | CA2637730A1 Soluble fragments of the sars-cov spike glycoprotein |
| 07/26/2007 | CA2637350A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 07/26/2007 | CA2636579A1 Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 07/26/2007 | CA2636566A1 A novel surface exposed haemophilus influenzae protein (protein e; pe) |
| 07/26/2007 | CA2632943A1 Novel synthetic agonists of toll-like receptors containing cg dinucleotide modifications |
| 07/26/2007 | CA2612467A1 Bispecific single chain fv antibody molecules and methods of use thereof |
| 07/25/2007 | EP1811035A1 Aspartic proteinase 2 (ASP2) |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1811025A1 Mutated amyloid protein |
| 07/25/2007 | EP1811020A1 Escherichia coli phytase |
| 07/25/2007 | EP1810980A1 Interleukin-6 inhibitors |
| 07/25/2007 | EP1810979A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 07/25/2007 | EP1810978A2 Group B streptococcus polypeptides nucleic acids and therapeutic composition and vaccines thereof |
| 07/25/2007 | EP1810691A2 Immunotherapy for reversing immune suppression |
| 07/25/2007 | EP1810690A1 Remedy for endometriosis |
| 07/25/2007 | EP1810687A1 Liver regeneration/repair controlling agent |
| 07/25/2007 | EP1810026A2 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer |
| 07/25/2007 | EP1809773A2 Yeast-based therapeutic for chronic hepatitis c infection |
| 07/25/2007 | EP1809742A2 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 07/25/2007 | EP1809737A2 Mature dendritic cell compositions and methods for culturing same |
| 07/25/2007 | EP1809673A2 Modulators of hepatocyte growth factor activator |
| 07/25/2007 | EP1809671A2 Targeted innate immunity |
| 07/25/2007 | EP1809670A2 Irta-4 antibodies and their uses |
| 07/25/2007 | EP1809658A2 Antigenic peptides |
| 07/25/2007 | EP1809326A2 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 07/25/2007 | EP1809325A2 Vaccines against japanese encephalitis virus and west nile virus |
| 07/25/2007 | EP1809323A1 Process for obtention of new cellular pertussis vaccine |
| 07/25/2007 | EP1809322A2 Domain ii mutants of anthrax lethal factor |
| 07/25/2007 | EP1809319A2 Anti-respiratory syncytial virus antibodies, antigens and uses thereof |
| 07/25/2007 | EP1809098A1 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 07/25/2007 | EP1355660B1 Composition and kit for use in the treatment of tumors |
| 07/25/2007 | EP1319184B1 Use of antibodies against specific mhc-peptide complexes |
| 07/25/2007 | EP1286686B1 E-selectin for treating or preventing stroke |
| 07/25/2007 | EP1200594B1 Protective antigen of epstein barr virus |
| 07/25/2007 | EP1042365B1 Compounds and methods for modulating occludin related tissue permeability |
| 07/25/2007 | EP0676965B1 Method of reducing immunogenicity of variable region of antibodies |
| 07/25/2007 | EP0665888B2 Ryegrass pollen allergen |
| 07/25/2007 | EP0637335B1 Recombinant mutants for inducing specific immune responses |
| 07/25/2007 | CN1328381C GnRH-leukotoxin chimeras |
| 07/25/2007 | CN1328373C Porcine circus-virus 2 type recombinant adenovirus and vaccine |
| 07/25/2007 | CN1328286C Aglyco products and method of use |
| 07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
| 07/25/2007 | CN1328021C Locking means and mini folding knife having locking means |
| 07/25/2007 | CN1327898C Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/25/2007 | CN1327897C Peptide derivative fusion inhibitors of HIV infection |
| 07/25/2007 | CN1327896C Compositions and method for treating viral infections |